ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
GSK at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
GSK brings 6 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2615. Its program centres on lupus, including earlier treatment to prevent progression, belimumab outcomes and lupus nephritis, along with B cell biology in systemic sclerosis skin and patient experience with EGPA treatment.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
GSK Durham, NC | |
Global pharmaceutical company developing and marketing medicines and vaccines. | Booth Exhibiting at Booth 2615 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Industry Sun Nov 8 5:30pm–7:30pm Preventing Progression in Lupus: Are You Intervening Early Enough? Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 12:30pm–1:15pm Clinical Insights in Lupus and LN: Revisiting Long-Standing Perceptions with Emerging Evidence |
Find decision makers at GSK
Tell us what you sell and we’ll find the people at GSK most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction